$7.93
0.060.76%
At Close: -
$8.02
0.091.13%
After Hours: 8:02 AM EDT
15 minutes delayed
Atara Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Atara Biotherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-3.10 | $-1.56 | -98.7 % |
Mar 2024 | 2024-05-09 | $-5.75 | $-6.50 | 11.5 % |
Dec 2023 | 2024-03-28 | $-14.00 | $-12.00 | -16.7 % |
Sep 2023 | 2023-11-01 | $-16.50 | $-16.50 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $28.64M | $39.99M | -28.4 % |
Mar 2024 | 2024-05-09 | $27.36M | $24.69M | 10.8 % |
Dec 2023 | 2024-03-28 | $4.25M | $11.55M | -63.2 % |
Sep 2023 | 2023-11-01 | $2.14M | $4.76M | -55.1 % |
Atara Biotherapeutics (ATRA) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-3.10, which missed the estimate of $-1.56.
The Actual Revenue was $28.6M, which missed the estimate of $40M.
Browse earnings estimates, EPS, and revenue on all stocks.